Hudson Bay Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
430,000
+61,450
| +17% | +$500K | 0.01% | 462 |
|
|
2025
Q1 | $2.89M | Buy |
368,550
+198,550
| +117% | +$1.56M | 0.01% | 462 |
|
|
2024
Q4 | $2.53M | Sell |
170,000
-5,000
| -3% | -$74.5K | 0.01% | 457 |
|
|
2024
Q3 | $2.68M | Buy |
175,000
+15,000
| +9% | +$229K | 0.01% | 394 |
|
|
2024
Q2 | $2.44M | Sell |
160,000
-5,000
| -3% | -$76.2K | 0.01% | 406 |
|
|
2024
Q1 | $3.12M | Sell |
165,000
-5,000
| -3% | -$94.4K | 0.02% | 332 |
|
|
2023
Q4 | $3.25M | Buy |
170,000
+90,000
| +113% | +$1.72M | 0.02% | 314 |
|
|
2023
Q3 | $1.44M | Sell |
80,000
-35,000
| -30% | -$628K | 0.01% | 446 |
|
|
2023
Q2 | $2.34M | Buy |
115,000
+200
| +0.2% | +$4.06K | 0.02% | 424 |
|
|
2023
Q1 | $2.09M | Buy |
114,800
+64,800
| +130% | +$1.18M | 0.02% | 476 |
|
|
2022
Q4 | $1.03M | Buy |
50,000
+25,000
| +100% | +$517K | 0.01% | 639 |
|
|
2022
Q3 | $654K | Sell |
25,000
-6,000
| -19% | -$157K | 0.01% | 838 |
|
|
2022
Q2 | $786K | Buy |
31,000
+21,000
| +210% | +$532K | 0.01% | 911 |
|
|
2022
Q1 | $316K | Buy |
+10,000
| New | +$316K | ﹤0.01% | 871 |
|
|
2020
Q4 | – | Sell |
-85,000
| Closed | -$1.46M | – | 671 |
|
|
2020
Q3 | $1.46M | Sell |
85,000
-25,000
| -23% | -$429K | 0.02% | 373 |
|
|
2020
Q2 | $2.72M | Buy |
+110,000
| New | +$2.72M | 0.05% | 265 |
|